IBDEI0DX ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6398,0)
 ;;=R35.0^^30^392^69
 ;;^UTILITY(U,$J,358.3,6398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6398,1,3,0)
 ;;=3^Micturition Frequency
 ;;^UTILITY(U,$J,358.3,6398,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,6398,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,6399,0)
 ;;=R35.1^^30^392^79
 ;;^UTILITY(U,$J,358.3,6399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6399,1,3,0)
 ;;=3^Nocturia
 ;;^UTILITY(U,$J,358.3,6399,1,4,0)
 ;;=4^R35.1
 ;;^UTILITY(U,$J,358.3,6399,2)
 ;;=^5019335
 ;;^UTILITY(U,$J,358.3,6400,0)
 ;;=R39.11^^30^392^70
 ;;^UTILITY(U,$J,358.3,6400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6400,1,3,0)
 ;;=3^Micturition Hesitancy
 ;;^UTILITY(U,$J,358.3,6400,1,4,0)
 ;;=4^R39.11
 ;;^UTILITY(U,$J,358.3,6400,2)
 ;;=^5019341
 ;;^UTILITY(U,$J,358.3,6401,0)
 ;;=R39.16^^30^392^101
 ;;^UTILITY(U,$J,358.3,6401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6401,1,3,0)
 ;;=3^Straining to Void
 ;;^UTILITY(U,$J,358.3,6401,1,4,0)
 ;;=4^R39.16
 ;;^UTILITY(U,$J,358.3,6401,2)
 ;;=^5019346
 ;;^UTILITY(U,$J,358.3,6402,0)
 ;;=R36.0^^30^392^103
 ;;^UTILITY(U,$J,358.3,6402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6402,1,3,0)
 ;;=3^Urethral Discharge w/o Blood
 ;;^UTILITY(U,$J,358.3,6402,1,4,0)
 ;;=4^R36.0
 ;;^UTILITY(U,$J,358.3,6402,2)
 ;;=^5019337
 ;;^UTILITY(U,$J,358.3,6403,0)
 ;;=R36.9^^30^392^104
 ;;^UTILITY(U,$J,358.3,6403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6403,1,3,0)
 ;;=3^Urethral Discharge,Unspec
 ;;^UTILITY(U,$J,358.3,6403,1,4,0)
 ;;=4^R36.9
 ;;^UTILITY(U,$J,358.3,6403,2)
 ;;=^5019338
 ;;^UTILITY(U,$J,358.3,6404,0)
 ;;=R97.2^^30^392^31
 ;;^UTILITY(U,$J,358.3,6404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6404,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,6404,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,6404,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,6405,0)
 ;;=R80.1^^30^392^93
 ;;^UTILITY(U,$J,358.3,6405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6405,1,3,0)
 ;;=3^Proteinuria Persistent,Unspec
 ;;^UTILITY(U,$J,358.3,6405,1,4,0)
 ;;=4^R80.1
 ;;^UTILITY(U,$J,358.3,6405,2)
 ;;=^5019596
 ;;^UTILITY(U,$J,358.3,6406,0)
 ;;=R80.0^^30^392^91
 ;;^UTILITY(U,$J,358.3,6406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6406,1,3,0)
 ;;=3^Proteinuria Isolated
 ;;^UTILITY(U,$J,358.3,6406,1,4,0)
 ;;=4^R80.0
 ;;^UTILITY(U,$J,358.3,6406,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,6407,0)
 ;;=R80.8^^30^392^94
 ;;^UTILITY(U,$J,358.3,6407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6407,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,6407,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,6407,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,6408,0)
 ;;=R80.3^^30^392^90
 ;;^UTILITY(U,$J,358.3,6408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6408,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,6408,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,6408,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,6409,0)
 ;;=R80.9^^30^392^95
 ;;^UTILITY(U,$J,358.3,6409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6409,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,6409,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,6409,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,6410,0)
 ;;=Z87.442^^30^392^83
 ;;^UTILITY(U,$J,358.3,6410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6410,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,6410,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,6410,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,6411,0)
 ;;=N18.1^^30^392^13
 ;;^UTILITY(U,$J,358.3,6411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6411,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,6411,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,6411,2)
 ;;=^5015602
